Cosmos Pharmaceutical
Cosmos Pharmaceutical Corp is a Japanese retail company that operates a major regional network of discount drugstores and dispensing pharmacies across Japan. The company operates large-format retail stores selling prescription pharmaceuticals, over-the-counter medicines, health supplements, cosmetics, personal care goods, and processed food products. Its retail operational strategy emphasizes low everyday pricing, large sales floor areas, and high-density store layouts in suburban residential areas. Principal revenue is derived from direct retail merchandise sales of food products, over-the-counter health goods, and cosmetics, alongside dispensing fees earned from processing medical prescriptions. Cosmos Pharmaceutical holds a prominent competitive position in the Japanese drugstore industry, recognized for its heavy sales contribution from daily grocery items. Headquartered in Fukuoka, Japan, the company's common stock is publicly listed and traded on the Prime Market of the Tokyo Stock Exchange under the ticker 3349.
11 of the funds FundTelligence covers report a position in Cosmos Pharmaceutical.
- Legal name
- Cosmos Pharmaceutical Corp
- Sector
- Consumer Staples
- Country
- Japan
- Funds holding it
- 11
Funds holding Cosmos Pharmaceutical
- Danske Invest Japan — Danske Invest · 1.68 % (full portfolio disclosed, August 2026)
- Baillie Gifford Worldwide Responsible Global Alpha Paris-Aligned Fund — Baillie Gifford · 0.78 % (full portfolio disclosed, September 2026)
- Baillie Gifford Worldwide Global Alpha Fund — Baillie Gifford · 0.66 % (full portfolio disclosed, September 2026)
- Schroder ISF Japanese Equity — Schroders · 0.64 % (full portfolio disclosed, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.02 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- Storebrand Global All Countries — Storebrand · 0.01 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 11 funds holding it.